Displaying drugs 4476 - 4500 of 11735 in total
Heptane-1,2,3-Triol
Experimental
N-[(Aminooxy)Carbonyl]Aniline
Experimental
Carbazochrome
Carbazochrome is a hemostatic agent that promotes clotting, preventing blood loss from open wounds. It is an oxidation product of adrenaline which enhances the microcirculatory tone . In the future this may prevent excessive blood flow during surgical operations and the treatment of hemorrhoids, but research on effectiveness and severity...
Experimental
Withdrawn
Matched Description: … Carbazochrome is a hemostatic agent that promotes clotting, preventing blood loss from open wounds. ... not FDA-approved but is available as tablets or IM/SC injections in the treatment of hemorrhages in a ... with [DB13124], and this combination therapy demonstrated efficacy and safe tolerability either at a …
Olomoucine
Experimental
1,2-Dihydroxybenzene
Experimental
Biphenyl-2,3-Diol
Experimental
4,5-Dimethyl-1,2-phenylenediamine
Experimental
3-methyl-benzene-1,2-diol
3-methyl-benzene-1,2-diol is a solid. This compound belongs to the catechols. These are compounds containing a 1,2-benzenediol moeity. 3-methyl-benzene-1,2-diol targets the protein biphenyl-2,3-diol 1,2-dioxygenase.
Experimental
Matched Description: … 3-methyl-benzene-1,2-diol is a solid. This compound belongs to the catechols. ... These are compounds containing a 1,2-benzenediol moeity. 3-methyl-benzene-1,2-diol targets the protein …
4-Methyl-1,2-Benzenediol
Experimental
MDL72527
Experimental
Metoprine
Experimental
Meldonium
Experimental
Heptamolybdate
Experimental
Dihydrouracil
Experimental
Estrane-3,17-dione
Estrane-3,17-dione is a potent inhibitor of isomerase.
Experimental
Matched Iupac: … (3aS,3bR,5aS,9aS,9bR,11aS)-11a-methyl-hexadecahydro-1H-cyclopenta[a]phenanthrene-1,7-dione …
Matched Description: … Estrane-3,17-dione is a potent inhibitor of isomerase. …
Matched Description: … Estrane-3,17-dione is a potent inhibitor of isomerase. …
Tavapadon
Tavapadon is under investigation in clinical trial NCT02262767 (A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 Co-administered With Trimethobenzamide Hydrochloride in Healthy Subjects).
Investigational
Matched Description: … , and Pharmacokinetics of PF-06649751 Co-administered With Trimethobenzamide Hydrochloride in Healthy ... Tavapadon is under investigation in clinical trial NCT02262767 (A Study to Investigate the Safety, Tolerability …
Patidegib
Patidegib has been investigated for the treatment of Conventional Chondrosarcoma.
Investigational
Matched Iupac: … ,6a,6b,7,7',7'a,8,10,12,12a,12b-icosahydro-1H,3'H-spiro[azuleno[2,1-a]naphthalene-9,2'-furo[3,2-b]pyridine ... N-[(3R,3'R,3'aS,4aR,6'S,6aR,6bS,7'aR,9S,12aS,12bS)-3',6',11,12b-tetramethyl-2,3,3'a,4,4',4a,5,5',6,6' …
DAR-0100A
DAR-0100A is under investigation in clinical trial NCT01466205 (Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder).
Investigational
Matched Iupac: … (6aR,12bS)-5H,6H,6aH,7H,8H,12bH-benzo[a]phenanthridine-10,11-diol …
Matched Description: … DAR-0100A is under investigation in clinical trial NCT01466205 (Clinical Testing of a D1 Agonist for …
Matched Description: … DAR-0100A is under investigation in clinical trial NCT01466205 (Clinical Testing of a D1 Agonist for …
Bimoclomol
Bimoclomol is an investigational drug that induces stress proteins and has cytoprotective effects.
Investigational
Dimethyl carbate
Dimethyl carbate is used as an insect repellant.
Experimental
Matched Iupac: … 2,3-dimethyl (1R,2S,3R,4S)-bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylate …
Anthranilic acid
Experimental
Allogeneic umbilical cord mesenchymal stem cells
Investigational
D-Proline
D-proline is an isomer of the naturally occurring amino acid, L-Proline. D-amino acids have been found in relatively high abundance in human plasma and saliva . These amino acids may be of bacterial origin, but there is also evidence that they are endogenously produced through amino acid racemase activity .
Experimental
Coagulin-B
Coagulin-B is an adeno-associated viral vector expressing human blood-coagulation Factor IX.[A259038, A259043] It was previously investigated for the treatment of hemophilia; however, the manufacturing company discontinued the Phase I trial in 2004, halting its further development and investigation.
Investigational
Coltuximab ravtansine
Coltuximab ravtansine (SAR3419) targets CD19 and is being investigated for the treatment of acute lymphoblastic leukemia (ALL).
Investigational
Displaying drugs 4476 - 4500 of 11735 in total